Key Takeaways
- • CME Group received regulatory approval from the Commodity Futures Trading Commission (CFTC) to launch bitcoin futures contracts, with trading commencing on December 18, 2017, marking the first major institutional derivatives product for cryptocurrency.
- • CFTC Chairman J. Christopher Giancarlo confirmed that CME, Cboe Futures Exchange (CFE), and Cantor Exchange all received clearance to offer bitcoin derivatives, with CME completing a rigorous six-week review process and CFE undergoing a four-month review.
- • Bitcoin price spiked 6 percent to $10,539 following the regulatory announcement on Friday, as the approval addressed a critical institutional adoption barrier and signaled potential downstream effects on bitcoin ETF approvals.
- • CME's stock rose 1.7 percent to an all-time high on the announcement, while Cboe's competitor contract filing suggests an accelerating competitive landscape for cryptocurrency derivatives infrastructure.
- • Industry observers, including Digital Currency Group founder Barry Silbert, identified the futures approval as a potential catalyst for bitcoin ETF approvals, which would represent a major institutional gateway for digital assets.
Summary
The CME Group announced Friday that it received regulatory green light from the Commodity Futures Trading Commission to launch bitcoin futures contracts, with trading set to begin on December 18, 2017. This approval represents a watershed moment for cryptocurrency derivatives, as CME becomes the world's largest futures exchange to formally enter the bitcoin market under federal supervision.
The CFTC's approval followed rigorous institutional scrutiny. According to CFTC Chairman J. Christopher Giancarlo's statement, commission staff engaged CME over six weeks of intensive discussions, noting that "Bitcoin, a virtual currency, is a commodity unlike any the Commission has dealt with in the past." The exchanges agreed to significant enhancements designed to protect customers and maintain orderly markets. Importantly, the CFTC clarified that it does not approve derivatives contracts or endorse their underlying assets—a distinction addressing regulatory concerns about implicit government endorsement of cryptocurrency.
The regulatory decision triggered immediate market response. Bitcoin traded 6 percent higher at $10,539 on Friday, representing a partial recovery from a 20 percent decline earlier in the week when the asset had fallen from a record high of $11,377.33. CME's stock price spiked 1.7 percent to an all-time high following the announcement, while Cboe's stock traded little changed after setting a record close the prior day. Cboe simultaneously filed a product certification to offer competing bitcoin futures contracts, indicating a competitive push among major derivatives platforms.
Industry executives emphasized broader strategic implications. Barry Silbert, founder and CEO of Digital Currency Group, stated on CNBC's "Squawk Box" that the futures approval "is going to enable finally the approval of bitcoin ETFs, and other digital currency ETFs, which is game changing." The comment underscores investor expectations that regulated exchange-traded derivatives could unlock the institutional investment vehicle long sought by the cryptocurrency sector. Additionally, Cantor Exchange self-certified a bitcoin binary options contract, expanding the range of derivative instruments available to market participants.
The CFTC's approval followed rigorous institutional scrutiny. According to CFTC Chairman J. Christopher Giancarlo's statement, commission staff engaged CME over six weeks of intensive discussions, noting that "Bitcoin, a virtual currency, is a commodity unlike any the Commission has dealt with in the past." The exchanges agreed to significant enhancements designed to protect customers and maintain orderly markets. Importantly, the CFTC clarified that it does not approve derivatives contracts or endorse their underlying assets—a distinction addressing regulatory concerns about implicit government endorsement of cryptocurrency.
The regulatory decision triggered immediate market response. Bitcoin traded 6 percent higher at $10,539 on Friday, representing a partial recovery from a 20 percent decline earlier in the week when the asset had fallen from a record high of $11,377.33. CME's stock price spiked 1.7 percent to an all-time high following the announcement, while Cboe's stock traded little changed after setting a record close the prior day. Cboe simultaneously filed a product certification to offer competing bitcoin futures contracts, indicating a competitive push among major derivatives platforms.
Industry executives emphasized broader strategic implications. Barry Silbert, founder and CEO of Digital Currency Group, stated on CNBC's "Squawk Box" that the futures approval "is going to enable finally the approval of bitcoin ETFs, and other digital currency ETFs, which is game changing." The comment underscores investor expectations that regulated exchange-traded derivatives could unlock the institutional investment vehicle long sought by the cryptocurrency sector. Additionally, Cantor Exchange self-certified a bitcoin binary options contract, expanding the range of derivative instruments available to market participants.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.